How condom use, number of receptive anal intercourse partners and history of external genital warts predict risk for external anal warts

International Journal of STD and AIDS

Volumn 16, Issue 3, 2005, Pages 203-211

  Wiley, D J ^a   Harper, Diane M ^b   Elashoff, David ^a   Silverberg, Michael J ^c   Kaestle, Christine ^d   Cook, Robert L ^e   Heilemann, MarySue ^a   Johnson, Lisette ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d The University of North Carolina at Chapel Hill   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

External genital warts; Receptive anal intercourse; Sexual behavioural risk factors

Indexed keywords

ADULT; AGED; ANUS INJURY; ARTICLE; COHORT ANALYSIS; CONDOM; CONDYLOMA; HIGH RISK PATIENT; HOMOSEXUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; WART VIRUS;

ANUS DISEASES; COHORT STUDIES; CONDOMS; CONDYLOMATA ACUMINATA; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS;

EID: 16344394388     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462053420176     Document Type: Article

References (76)

1. Centers for Disease Control and Prevention. STD Surveillance 2003. Atlanta, GA: US Department of Health and Human Services, September, 2004
2. Giannini SL, Hubert P, Doyen J, Boniver J, Delvenne P. Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Int J Cancer 2002;97:654-9
3. Ji HX, Yliskoski M, Vayrynen M, Hippelainen M, Syrjanen S, Syrjanen K. Colposcopic analysis of genital human papillomavirus infections during an 8-year prospective follow-up. Int J Gynaecol Obstet 1991;36:291-300
4. Reid R. Human papillomaviral infection. The key to rational triage of cervical neoplasia. Obstet Gynecol Clin North Am 1987;14:407-29
5. Murdoch JB, Cassidy LJ, Fletcher K, Cordiner JW, Macnab JC. Histological and cytological evidence of viral infection and human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and normal tissue in the west of Scotland. Evaluation of treatment policy. BMJ 1988;296:381-5
6. Melbye M, Frisch M. The role of human papillomaviruses in anogenital cancers. Semin Cancer Biol 1998;8:307-13
7. Ylitalo N, Josefsson A, Melbye M, et al. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 2000;60:6027-32
8. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997;337:1350-8
9. Frisch M, Glimelius B, van den Brule AJ, et al. Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma. Br J Cancer 1998;78:1534-8
10. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92:1500-10
11. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001;93:843-9
12. Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001;183:383-91
13. Palefsky JM, Holly EA, Ralston ML, Arthur SP, Hogeboom CJ, Darragh TM. Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Genitourin Med 1997;73:174-80
14. Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr 1998;15-20
15. Palefsky JM, Holly EA, Ralston ML, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:320-6
16. Massad LS, Riester KA, Anastos KM, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 1999;21:33-41
17. Palefsky JM. Anal squamous intraepithelial lesions: relation to HIV and human papillomavirus infection. J Acquir Immune Defic Syndr 1999;21:S42-8
18. Surawicz CM, Kirby P, Critchlow C, Sayer J, Dunphy C, Kiviat N. Anal dysplasia in homosexual men: role of anoscopy and biopsy. Gastroenterology 1993;105:658-66
19. Palefsky JM. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1994;8:283-95
20. Palefsky JM, Gonzales J, Greenblatt RM, Ahn DK, Hollander H. Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease. JAMA 1990;263:2911-16
21. Palefsky JM, Holly EA, Gonzales J, Lamborn K, Hollander H. Natural history of anal cytologic abnormalities and papillomavirus infection among homosexual men with group IV HIV disease. J Acquir Immune Defic Syndr 1992;5:1258-65
22. Palefsky JM, Holly EA, Hogeboom CJ, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:314-19
23. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998;177:361-7
24. Palefsky JM, Shiboski S, Moss A. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr 1994;7:599-606
25. Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum 2002;45:453-8
26. Palefsky J, del Rio C. Is high-grade dysplasia on anal Pap a high-grade problem? AIDS Clin Care 2002;14:44-5
27. Da Costa MM, Hogeboom CJ, Holly EA, Palefsky JM. Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 2002;185:1229-37
28. Palefsky JM, Berline J, Greenspan D, Greenspan JS. Evidence for trafficking of Epstein-Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes. J Gen Virol 2002;83:317-21
29. Palefsky JM, Holly EA, Ralston ML, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr 2001;28:422-8
30. Palefsky J, Holly E, Ralston M, Jay N, Berry J, Darragh T. Effect of HAART on incidence of anal intraepithelial neoplasia grade 3 among HIV-positive men who have sex with men In: XIV International AIDS Conference. Barcelona, Spain, July 2002; 7-12
31. Kanetsky PA, Gammon MD, Mandelblatt J, et al. Cigarette smoking and cervical dysplasia among non-Hispanic black women. Cancer Detect Prev 1998;22:109-19
32. Ho GY, Kadish AS, Burk RD, et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intraepithelial neoplasia. Int J Cancer 1998;78:281-5
33. Hildesheim A, Herrero R, Castle PE, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001;84:1219-26
34. Ylitalo N, Sorensen P, Josefsson A, et al. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer 1999;81:357-65
35. Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women (see comments). J Natl Cancer Inst 1999;91:226-36
36. Frazer IH, Medley G, Crapper RM, Brown TC, Mackay IR. Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet 1986;ii:657-60
37. Laga M, Icenogle JP, Marsella R, et al. Genital papillomavirus infection and cervical dysplasia - opportunistic complications of HIV infection. Int J Cancer 1992;50:45-8
38. Kiviat NB, Critchlow CW, Holmes KK, et al. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS 1993;7:43-9
39. Seck AC, Faye MA, Critchlow CW, et al. Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV. Int J STD AIDS 1994;5:189-93
40. Wright Jr TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol 1994;84:591-7
41. Branca M, Delfino A, Rossi E, et al. Cervical intraepithelial neoplasia and human papillomavirus related lesions of the genital tract in HIV positive and negative women. Eur J Gynaecol Oncol 1995;16:410-17
42. Palefsky JM. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol 2000;27:471-9
43. Dillner J, Kallings I, Brihmer C, et al. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis 1996;173:1394-8
44. Wheeler CM, Parmenter CA, Hunt WC, et al. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 1993;20:286-9
45. Hildesheim A, Gravitt P, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, DC. Sex Transm Dis 1993;20:279-85
46. Hildesheim A, Han CL, Brinton LA, Kurman RJ, Schiller JT. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol 1997;90:748-54
47. Joffe GP, Foxman B, Schmidt AJ, et al. Multiple partners and partner choice as risk factors for sexually transmitted disease among female college students. Sex Transm Dis 1992;19:272-8
48. de Sanjose S, Bosch FX, Munoz N, Shah K. Social differences in sexual behaviour and cervical cancer. IARC Sci Publ 1997;309-17
49. Kjaer SK, Chackerian B, van den Brule AJ, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001;10:101-6
50. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo Jr CR. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-18
51. Chmiel JS, Detels R, Kaslow RA, Van Raden M, Kingsley LA, Brookmeyer R. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol 1987;126:568-77
52. Wiley DJ, Grosser S, Qi K, et al. Validity of self-reporting of episodes of external genital warts. Clin Infect Dis 2002;35:39-45
53. Beutner KR, Richwald GA, Wiley DJ, Reitano MV. External genital warts: report of the American Medical Association Consensus Conference. AMA Expert Panel on External Genital Warts. Clin Infect Dis 1998;27:796-806
54. Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol 1983;1:710-19
55. Anderson JR, Cain KC, Gelber RD, Gelman RS. Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials. Cancer Treat Rep 1985;69:1139-46
56. SAS Institute Inc. SAS Language: Reference, Version 8. 1st edn. Cary: SAS Institute Inc, 1999
57. SAS Institute Inc. SAS Stat: Chapter 29. Cary: SAS Institute Inc., 1999
58. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002;29:725-35
59. Wen LM, Estcourt CS, Simpson JM, Mindel A. Risk factors for the acquisition of genital warts: are condoms protective? Sex Transm Infect 1999;75:312-16
60. Wiley DJ, Visscher BR, Grosser S, et al. Evidence that anoreceptive intercourse with ejaculate exposure is associated with rapid CD4 cell loss. AIDS 2000;14:707-15
61. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285:2995-3002
62. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988;10:122-63
63. Critchlow CW, Hawes SE, Kuypers JM, et al. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS 1998;12:1177-84
64. Breese PL, Judson FN, Penley KA, Douglas Jr JM. Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus. Sex Transm Dis 1995;22:7-14
65. Van Doornum GJ, Prins M, Juffermans LH, et al. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourinary Med 1994;70:240-6
66. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer [see comments]. N Engl J Med 1997;337:1350-8
67. Hippelainen MI, Hippelainen M, Saarikoski S, Syrjanen K. Clinical course and prognostic factors of human papillomavirus infections in men. Sex Transm Dis 1994;21:272-9
68. Hippelainen M, Syrjanen S, Koskela H, Pulkkinen J, Saarikoski S, Syrjanen K. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis 1993;20:321-8
69. Bleeker MC, Hogewoning CJ, Voorhorst FJ, et al. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer 2003;107:804-10
70. Adam MB, Auerbach JD, Buehler JW, et al. Workshop Summary: Scientific Evidence on Condom Effectiveness for Sexually Transmitted Disease (STD) Prevention. Herndon, VA: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, 12-13 June 2000
71. Boxman IL, Hogewoning A, Mulder LH, Bouwes Bavinck JN, ter Schegget J. Detection of human papillomavirus types 6 and 11 in pubic and perianal hair from patients with genital warts. J Clin Microbiol 1999;37:2270-3
72. Hogewoning CJ, Bleeker MC, van den Brule AJ, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003;107:811-6
73. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8
74. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998;12:495-503
75. Goldstone SE, Winkler B, Ufford LJ, Alt E, Palefsky JM. High prevalence of anal squamous intraepithelial lesions and squamous-cell carcinoma in men who have sex with men as seen in a surgical practice. Dis Colon Rectum 2001;44:690-8
76. Dosemeci M, Wacholder S, Lubin JH. Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol 1990;132:746-8